2026-01-20 - Analysis Report
**ISRG Intuitive Surgical Analysis Report**
=====================================================

**Company Overview**
-------------------

Intuitive Surgical, Inc. is a leading medical technology company that designs, manufactures, and markets robotic-assisted surgery systems.

**Return Rate Comparison**
-------------------------

* Cumulative return of review stock: 69.99%
* Cumulative return of comparison stock (S&P 500, VOO): 93.30%
* Divergence: -23.30 (relative divergence: 20.10%)

**Alpha, Beta Analysis**
-------------------------

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|------|-------|-------|
| 2016-2018  | 49.0% | 29.0% | 44.0% | 1.2 | 57.2B |
| 2017-2019  | 40.0% | 29.0% | 23.0% | 1.4 | 70.7B |
| 2018-2020  | -8.0% | 29.0% | -29.0% | 1.2 | 97.8B |
| 2019-2021  | 26.0% | 21.1% | -18.0% | 1.2 | 128.8B |
| 2020-2022  | -18.0% | 48.9% | -16.0% | 1.2 | 95.1B |
| 2021-2023  | -12.0% | 48.9% | -13.0% | 1.4 | 121.0B |
| 2022-2024  | 35.0% | 38.0% | 16.0% | 1.3 | 187.1B |
| 2023-2025  | 60.0% | 28.0% | -2.0% | 1.2 | 203.1B |

**Recent Stock Price Fluctuations**
---------------------------------

* Close: $535.00
* Last-market: {'price': 535.068, 'previousClose': 541.272, 'change': -1.15}
* 5-day SMA: $551.53
* 20-day SMA: $570.17
* 60-day SMA: $560.99

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**
----------------------------------------------------------------

* Market Risk Indicator (MRI): 0.80
* RSI: 29.97
* PPO: -0.99
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.80)
* Recent (20 days) relative divergence change: -12.90 (-): worsening
* 7-day Rank change: 10 (+): rank up
* 7-day Dynamic Expected Return change: 3.00 (+): improving
* Expected Return (%): 8.30%

**Recent News & Significant Events**
------------------------------------

* 2026-01-19: Is PODD A Better Bet Than ISRG Stock? - Forbes
* 2026-01-14: Why Intuitive Surgical Stock Dropped Today - The Motley Fool
* 2026-01-06: Taking A Fresh Look At Intuitive Surgical (ISRG) Valuation After A Strong Recent Share Price Run - Yahoo Finance
* 2026-01-12: Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know - Nasdaq
* 2026-01-19: ISRG NASDAQ pre-market $535.00 19 Jan 2026: AI investors note earnings - Meyka

**Analyst Opinions**
--------------------

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
- Opinions: 29
- Target Price (avg/high/low): 608.26 / 740.00 / 378.00

**Recent Earnings Analysis**
---------------------------

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-22 | 1.98 | 2.51 B$ |
| 2025-07-23 | 1.84 | 2.44 B$ |
| 2025-04-23 | 1.95 | 2.25 B$ |
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2025-10-22 | 1.59 | 2.04 B$ |

**Financial Information: Revenue and Profitability**
------------------------------------------------

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $2.51B | 66.36% |
| 2025-06-30 | $2.44B | 66.31% |
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |

**Financial Information: Capital and Profitability**
-----------------------------------------------------

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $16.93B | 4.16% |
| 2025-06-30 | $17.85B | 3.69% |
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |

**Comprehensive Analysis**
-------------------------

The company has shown a relatively stable growth trend in terms of revenue and profitability. However, the recent stock price fluctuations indicate a decline in performance, with a 5-day SMA of $551.53 and a 20-day SMA of $570.17. The RSI and PPO indicators suggest a neutral to bearish trend, while the market risk indicator indicates a medium-risk investment opportunity. The analyst consensus is overwhelmingly positive, with a buy recommendation from 92.6% of analysts.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.